STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more

Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription drug pricing. It’s a big victory for the pharmaceutical industry:
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks